Home » Archive by Category

News

San Diego biotech news from BioSpace, Xconomy, PR Newswire, Marketwired and other sources, click on headlines to read the full story.

Vical Incorporated Reports Third Quarter 2014 Financial Results And Progress In Key Development Programs

October 30, 2014 – 5:00 am | Edit Post

SAN DIEGO, Oct. 30, 2014 (GLOBE NEWSWIRE) — Vical Incorporated (Nasdaq:VICL) today reported financial results for the three months and nine months ended September 30, 2014. The net loss for the third quarter of 2014 was $4.4 million, or $0.05 per share, compared with a net loss of $9.9 million, or…

North County Medical Group Aims to Raise the 64%

October 30, 2014 – 5:00 am | Edit Post

VISTA, CA–(Marketwired – Oct 30, 2014) – In 2012 the Affordable Care Act determined that women over 40 are entitled to breast cancer mammography screenings every 1 to 2 years. So why is the national average for mammogram screenings for eligible individuals at only 64%? A local North County San Diego medical group is taking this question personally. After all, the best defense again breast cancer is early detection.

Auspex Pharmaceuticals Initiates Second Pivotal Clinical Trial For SD-809 In Tardive Dyskinesia

October 30, 2014 – 5:00 am | Edit Post

LA JOLLA, Calif., Oct. 30, 2014 (GLOBE NEWSWIRE) — Auspex Pharmaceuticals, Inc. (Nasdaq:ASPX), a biopharmaceutical company dedicated to developing innovative medicines for people with movement disorders and other rare diseases, today announced the enrollment of the first patient in a multi-center Phase…

Alphatec Spine To Showcase New Arsenal Spinal Fixation System At The Upcoming 29th Annual North American Spine Society Meeting In San Francisco

October 30, 2014 – 5:00 am | Edit Post

CARLSBAD, Calif., Oct. 29, 2014 (GLOBE NEWSWIRE) — Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a global provider of spinal fusion technologies, announced today that it will showcase its new spinal fixation system, Arsenal as well as its comprehensive portfolio…

Aptose Biosciences To Host Conference Call And Webcast For Four Month Interim Period Ended September 30, 2014

October 30, 2014 – 5:00 am | Edit Post

SAN DIEGO and TORONTO, Oct. 30, 2014 /PRNewswire/ – Aptose Biosciences Inc. (Aptose) (NASDAQ: APTO; TSX:APS), a clinical-stage company developing targeted agents and molecular diagnostics to treat the underlying mechanisms of cancer, today announced it intends…

Immunomedics, Inc. Provides Update On Phase 2 Study Of Isactuzumab Govitecan In Patients With Diverse Metastatic Solid Cancers

October 30, 2014 – 5:00 am | Edit Post

SAN DIEGO, Oct. 29, 2014 (GLOBE NEWSWIRE) — Immunomedics, Inc., (Nasdaq:IMMU) today announced that isactuzumab govitecan (IMMU-132), the Company’s proprietary solid-tumor antibody-drug conjugate (ADC), continues to produce encouraging results in a Phase 2 clinical trial in heavily…

Fate Therapeutics To Present At Nomura Biotechnology Conference

October 30, 2014 – 5:00 am | Edit Post

SAN DIEGO, Oct. 30, 2014 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (Nasdaq:FATE), a biopharmaceutical company engaged in the discovery and development of adult stem cell modulators to treat orphan diseases, announced today that Christian Weyer, M.D., M.A.S., President and Chief Executive Officer will…

Neurocrine Biosciences, Inc. Receives Breakthrough Therapy Designation For NBI-98854 In Tardive Dyskinesia

October 30, 2014 – 5:00 am | Edit Post

SAN DIEGO, Oct. 30, 2014 /PRNewswire/ –Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for its Vesicular Monoamine Transporter 2 inhibitor, NBI-98854, in tardive dyskinesia. A breakthrough therapy designation…

GreatCall Adds AliveCor Heart Monitor To Mobile Health Portfolio

October 30, 2014 – 5:00 am | Edit Post

Connection to Touch3 smartphone brings mobile heart health tracking directly to patients and their physicians SAN DIEGO October 30, 2014 GreatCall, Inc., the leader in creating mobile health and safety solutions for active aging, is bringing the ability to affordably track heart health anywhere, anytime to its Touch3 smartphone as a pilot program. The AliveCor Heart Monitor…

Volcano Corporation Schedules Third Quarter Conference Call, Webcast

October 30, 2014 – 5:00 am | Edit Post

SAN DIEGO, Oct. 29, 2014 /PRNewswire/ –Volcano Corporation (Nasdaq: VOLC), a leading company focused on improving patient and economic outcomes on a global basis by developing and delivering innovative minimally invasive coronary and peripheral visualization, physiology diagnostics and therapies, today announced…